ARCHIVES

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

This article is from The Cancer Letter archive.

Vol. 30 No. 26 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

In Brief: Carter Transition Team Lists Prospects For HEW Secretary; Interferon Available

December 3, 1976

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005